IMCC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IM Cannabis Corp (IMCC) is not a strong buy for a beginner investor with a long-term focus. The stock faces significant risks, including a Nasdaq compliance notice and weak technical indicators. While the company has shown some financial improvement in revenue and net income, its overall financial health remains poor, and there are no strong positive catalysts or trading signals to justify immediate investment.
The MACD is positive and expanding, which is a mildly bullish signal. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. Key support is at 0.311, and resistance is at 0.391. The stock is trading below its pivot point, suggesting weakness.
The company is actively working to regain Nasdaq compliance, which shows commitment to maintaining its listing.
The company received a Nasdaq compliance notice for failing to meet the $1.00 minimum bid price requirement, posing a delisting risk. Gross margin dropped significantly by -97.41% YoY, and the stock is in a bearish technical trend.
In Q4 2025, revenue increased to $15.68M (+17.62% YoY), and net income improved to -$7.63M (+655.09% YoY). However, the EPS remains negative at -1.33, and gross margin fell sharply to 0.52 (-97.41% YoY), indicating profitability challenges.
No analyst rating or price target changes available.
